Presentation
7 March 2022 Rationally designed light-activatable nanocomplex for multi-tier cancer cell targeting and photochemotherapy
Author Affiliations +
Abstract
Combination treatments are most effective when targeting different cancer survival and growth pathways. Nanotechnology combined with photochemistry provides a unique opportunity to simultaneously deliver and activate multiple drugs that target all major regions of a cancer cell—plasma membrane, cytoplasm, and nucleus. In this study, we developed a light-activatable nanocomplex that selectively and simultaneously deliver three clinically relevant therapeutic agents at a synergistic drug ratio to destroy ovarian cancer cells, while sparing normal tissues.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Barry J. Liang, Michael Pigula, Yan Baglo, Daniel Najafali, Tayyaba Hasan, and Huang-Chiao Huang "Rationally designed light-activatable nanocomplex for multi-tier cancer cell targeting and photochemotherapy", Proc. SPIE PC11940, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic and Photobiomodulation Therapy XXX, (7 March 2022); https://doi.org/10.1117/12.2609687
Advertisement
Advertisement
KEYWORDS
Cancer

Oncology

Plasma

Optical imaging

Ovarian cancer

Photodynamic therapy

Proteins

Back to Top